Evidence map›Paper›PMID 26646023›Full record

ArticleAnesthesiology2016

Insulin Signaling in Bupivacaine-induced Cardiac Toxicity: Sensitization during Recovery and Potentiation by Lipid Emulsion.

Michael R Fettiplace, Katarzyna Kowal, Richard Ripper, Alexandria Young, Kinga Lis, Israel Rubinstein, Marcelo Bonini, Richard Minshall, Guy Weinberg

Abstract read
In one paragraph

Article in Anesthesiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. BDNF-TrkB/proBDNF-p75Scientific reports · 2023
    Article
  4. Review
  5. Reply to the letter to the editor.European heart journal. Case reports · 2023
    Article
  6. Article
  7. The Yin and Yang Effect of the Apelinergic System in Oxidative Stress.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Lipid Emulsion for Treating Local Anesthetic Systemic Toxicity.International journal of medical sciences · 2018
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Michael R FettiplaceFrom the Department of Anesthesiology (M.R.F., K.K., R.R., A.Y., K.L., R.M., G.W.) and Department of Medicine (I.R., M.B.), and Neuroscience Program (M.R.F.), University of Illinois at Chicago, Chicago, Illinois; and Research and Development Service, Jesse Brown Veterans Affairs Medical Center (M.R.F., K.K., R.R., A.Y., K.L., I.R., G.W.), Chicago, Illinois.
Katarzyna Kowal
Richard Ripper
Alexandria Young
Kinga Lis
Israel Rubinstein
Marcelo Bonini
Richard Minshall
Guy Weinberg
University of Illinois Chicago · US

Funding

Intralipid: A novel frontline countermeasure for brodifacoum poisoningU01NS083457 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI FEINSTEIN, DOUGLAS L. · 2013 to 2018
$3.6M
Mechanisms and translation of lipid resuscitationI01BX001514 · VA · JESSE BROWN VA MEDICAL CENTER · PI RUBINSTEIN, ISRAEL, WEINBERG, GUY L · 2013 to 2016
–
BLRD VA I01 BX001514Intramural VA VA999999NINDS NIH HHS 1U01NS083457-01NINDS NIH HHS U01 NS083457
6 · The paper itself

Abstract

backgroundThe impact of local anesthetics on the regulation of glucose homeostasis by protein kinase B (Akt) and 5'-adenosine monophosphate-activated protein kinase (AMPK) is unclear but important because of the implications for both local anesthetic toxicity and its reversal by IV lipid emulsion (ILE).

methodsSprague-Dawley rats received 10 mg/kg bupivacaine over 20 s followed by nothing or 10 ml/kg ILE (or ILE without bupivacaine). At key time points, heart and kidney were excised. Glycogen content and phosphorylation levels of Akt, p70 s6 kinase, s6, insulin receptor substrate-1, glycogen synthase kinase-3β, AMPK, acetyl-CoA carboxylase, and tuberous sclerosis 2 were quantified. Three animals received Wortmannin to irreversibly inhibit phosphoinositide-3-kinase (Pi3k) signaling. Isolated heart studies were conducted with bupivacaine and LY294002-a reversible Pi3K inhibitor.

resultsBupivacaine cardiotoxicity rapidly dephosphorylated Akt at S473 to 63 ± 5% of baseline and phosphorylated AMPK to 151 ± 19%. AMPK activation inhibited targets downstream of mammalian target of rapamycin complex 1 via tuberous sclerosis 2. Feedback dephosphorylation of IRS1 to 31 ± 8% of baseline sensitized Akt signaling in hearts resulting in hyperphosphorylation of Akt at T308 and glycogen synthase kinase-3β to 390 ± 64% and 293 ± 50% of baseline, respectively. Glycogen accumulated to 142 ± 7% of baseline. Irreversible inhibition of Pi3k upstream of Akt exacerbated bupivacaine cardiotoxicity, whereas pretreating with a reversible inhibitor delayed the onset of toxicity. ILE rapidly phosphorylated Akt at S473 and T308 to 150 ± 23% and 167 ± 10% of baseline, respectively, but did not interfere with AMPK or targets of mammalian target of rapamycin complex 1.

conclusionGlucose handling by Akt and AMPK is integral to recovery from bupivacaine cardiotoxicity and modulation of these pathways by ILE contributes to lipid resuscitation.

Indexed as

AMP-Activated Protein KinasesAnesthesia Recovery PeriodAnesthetics, LocalAnimalsBlotting, WesternBupivacaineCardiotoxicityDisease Models, AnimalDrug SynergismFat Emulsions, IntravenousGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHeartInsulinIn Vitro TechniquesMyocardiumAMP-Activated Protein KinasesAnesthetics, LocalBupivacaineFat Emulsions, IntravenousGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, ratInsulinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID26646023
PMCPMC4718826
OpenAlexW2191568640

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.